ArticleJournal of the American Academy of Dermatology2025
Infection risk of rituximab monotherapy versus combination therapy with rituximab and mycophenolic acid in systemic sclerosis: A retrospective cohort study.
Joyce B Kang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.